CB 183
Alternative Names: CB-183Latest Information Update: 08 Mar 2023
Price :
$50 *
At a glance
- Originator Chimeron Bio
- Class RNA vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Viral infections
Most Recent Events
- 25 Jan 2023 Early research in Viral infections (Prevention) in USA (unspecified route) (Chimeron Bio pipeline, January 2023)